Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference18 articles.
1. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
2. Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, Kritas SK. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J BiolRegul Homeost Agents. 2020. https://doi.org/10.23812/CONTI-E.
3. Siddiqui HK, Mehra MR. Illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplantation COVID-19
4. Chen J, Liu D, Li L, Liu P, Xu Q, Xia L, et al. A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19). J Zhejiang Univ (MedSci). 2020. https://doi.org/10.3785/j.issn.1008-9292.2020.03.03.
5. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020. https://doi.org/10.1016/j.ijantimicag.2020.105949.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献